Schöneberger Verena, Schirrwagen Julia, Brockmann Claudia, Fuchsluger Thomas A, Schaub Friederike
Department of Ophthalmology, University Medical Center Rostock, Doberaner Strasse 140, 18057, Rostock, Germany.
Department of Ophthalmology, Medical Faculty, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Int J Retina Vitreous. 2025 Jul 29;11(1):86. doi: 10.1186/s40942-025-00712-2.
Secondary epiretinal membranes (sERM) are common in uveitis and often associated with cystoid macular edema (CME), which increases the need for anti-inflammatory treatment. While surgical removal can improve anatomical and visual outcomes, its effect on intraocular inflammation and steroid requirement remains unclear. This study evaluates whether vitrectomy with ERM peeling can reduce the need for postoperative steroid therapy in uveitic eyes.
This retrospective single-center study reviewed 67 eyes of 67 patients with history of uveitis who underwent sERM peeling between 11/2002 and 04/2023. Demographic data, uveitis classification (SUN), spectral domain optical coherence tomography (SD-OCT) findings, and pre-/postoperative steroid requirements were analyzed. Statistical significance testing was performed using a paired two-tailed t-test.
Of the 67 eyes, 50.7% were right eyes, and 65.7% of patients were female. Mean age at timepoint of surgery was 63.1 ± 13.6 years, with 53.7% phakic eyes. Uveitis was classified as anterior (17.9%), intermediate (44.8%), posterior (31.3%), and panuveitis (6.0%). Steroid therapy was reduced in 28.4% of patients, remained unchanged in 56.7%, and increased in 14.9%. Preoperatively, cystoid macular edema (CME) was present in 41.4% of the 58 available SD-OCT scans. Postoperatively, retinal thickness, macular volume, and total retinal volume decreased significantly (p < 0.001). Postoperative CME was found in 31.3% in first postoperative SD-OCT and was newly observed in 6.0%, while 62.7% showed no CME.
ERM peeling in uveitic eyes does not guarantee functional improvement or a consistent reduction in steroid dependency. While approximately one-third of patients benefited from reduced steroid use-particularly those with preoperative CME-the majority showed no change, and a subset required intensified therapy due to postoperative inflammation or CME recurrence. Careful patient selection remains essential.
继发性视网膜前膜(sERM)在葡萄膜炎中很常见,且常与黄斑囊样水肿(CME)相关,这增加了抗炎治疗的需求。虽然手术切除可改善解剖结构和视力结果,但其对眼内炎症和类固醇需求的影响仍不明确。本研究评估玻璃体切除联合ERM剥除术是否能减少葡萄膜炎患眼术后类固醇治疗的需求。
这项回顾性单中心研究纳入了2002年11月至2023年4月期间接受sERM剥除术的67例葡萄膜炎患者的67只眼。分析了人口统计学数据、葡萄膜炎分类(SUN)、频域光学相干断层扫描(SD-OCT)结果以及术前/术后类固醇需求。使用配对双尾t检验进行统计学显著性检验。
67只眼中,50.7%为右眼,65.7%的患者为女性。手术时的平均年龄为63.1±13.6岁,53.7%为有晶状体眼。葡萄膜炎分类为前葡萄膜炎(17.9%)、中间葡萄膜炎(44.8%)、后葡萄膜炎(31.3%)和全葡萄膜炎(6.0%)。28.4%的患者类固醇治疗减少,56.7%保持不变,14.9%增加。术前,58份可用的SD-OCT扫描中有41.4%存在黄斑囊样水肿(CME)。术后,视网膜厚度、黄斑体积和视网膜总体积显著下降(p<0.001)。术后首次SD-OCT检查发现31.3%存在CME,6.0%为新出现的CME,而62.7%未发现CME。
葡萄膜炎患眼的ERM剥除术不能保证功能改善或类固醇依赖的持续减少。虽然约三分之一的患者从减少类固醇使用中获益——尤其是术前有CME的患者——但大多数患者无变化,一小部分患者因术后炎症或CME复发需要强化治疗。谨慎选择患者仍然至关重要。